A Preterm Infant of Congenital Cutaneous Candidiasis With Elevated Plasma (1, 3) β-D-glucan Level-Reference-Cited by-同舟云学术

A Preterm Infant of Congenital Cutaneous Candidiasis With Elevated Plasma (1, 3) β-D-glucan Level

Published:2024-06-25 Issue: Volume: Page:
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Watanabe Shunsuke¹²^ORCID,Hoshina Takayuki¹,Miyamoto Tomonari¹,Suga Shutaro¹²,Komatsu Kazuki³,Tajiri Ryosuke²⁴,Kusuhara Koichi¹

Affiliation:

1. Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan

2. Department of Neonatology, General Perinatal Medical Center, Hospital of University of Occupational and Environmental Health, Japan, Kitakyushu, Japan

3. Department of Pathology and Oncology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan

4. Department of Obstetrics and Gynecology, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference5 articles.

1. Invasive fungal dermatitis in the < or = 1000-gram neonate.;Rowen;Pediatrics,1995

2. Congenital cutaneous candidiasis: clinical presentation, pathogenesis, and management guidelines.;Darmstadt;Pediatrics,2000

3. Diagnostic accuracy of serum (1,3)-beta-d-glucan for neonatal invasive candidiasis: systematic review and meta-analysis.;Cohen;Clin Microbiol Infect,2020

4. Influence of various hemodialysis membranes on the plasma (1-->3)-beta-D-glucan level.;Kanda;Kidney Int,2001

5. Efficacy of the new β-D-glucan measurement kit for diagnosing invasive fungal infections, as compared with that of four conventional kits.;Bamba;PLoS One,2021